UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 393

Sortiert nach

Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (5), p.737-746

2016

Link zum Volltext

Verfügbarkeit prüfen

Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: A review

Journal of ethnopharmacology, 2013-08, Vol.149 (1), p.35-48

Zhao, Ying-Yong

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis

British journal of pharmacology, 2018-07, Vol.175 (13), p.2689-2708

2018

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation

Cellular and molecular life sciences : CMLS, 2021-02, Vol.78 (3), p.909-922

2021

Link zum Volltext

Verfügbarkeit prüfen

Architectures and accuracy of artificial neural network for disease classification from omics data

BMC genomics, 2019-03, Vol.20 (1), p.167-167, Article 167

2019

Link zum Volltext

Verfügbarkeit prüfen

Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis

Medicinal research reviews, 2020-01, Vol.40 (1), p.54-78

2020

Link zum Volltext

Verfügbarkeit prüfen

Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease

Cellular and molecular life sciences : CMLS, 2019-12, Vol.76 (24), p.4961-4978

2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine

Chemico-biological interactions, 2017-08, Vol.273, p.133-141

2017

Link zum Volltext

Verfügbarkeit prüfen

Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease

Journal of translational medicine, 2019-01, Vol.17 (1), p.5-5, Article 5

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation

British journal of pharmacology, 2020-08, Vol.177 (15), p.3415-3435

2020

Link zum Volltext

Verfügbarkeit prüfen

Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis

Experimental and Molecular Medicine, 2019, 51(0), , pp.1-18

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

Nature communications, 2019-04, Vol.10 (1), p.1476-1476, Article 1476

2019

Link zum Volltext

Verfügbarkeit prüfen

1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway

British journal of pharmacology, 2022-01, Vol.179 (1), p.103-124

2022

Link zum Volltext

Verfügbarkeit prüfen

Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites

British journal of pharmacology, 2024-01, Vol.181 (1), p.162-179

2024

Link zum Volltext

Verfügbarkeit prüfen

Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy

Biomedicine & pharmacotherapy, 2019-09, Vol.117, p.108990-108990, Article 108990

2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans

Journal of proteome research, 2016-10, Vol.15 (10), p.3802-3812

2016

Link zum Volltext

Verfügbarkeit prüfen

Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism

PloS one, 2013-03, Vol.8 (3), p.e59617

2013

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy

Scientific reports, 2015-08, Vol.5 (1), p.12936-12936, Article 12936

2015

Link zum Volltext

Verfügbarkeit prüfen

Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma

Journal of translational medicine, 2019-09, Vol.17 (1), p.302-302, Article 302

2019

Link zum Volltext

Verfügbarkeit prüfen

Ultra-performance liquid chromatography–mass spectrometry as a sensitive and powerful technology in lipidomic applications

Chemico-biological interactions, 2014-09, Vol.220, p.181-192

2014

Link zum Volltext

Verfügbarkeit prüfen

The Matrix Metalloproteinase‐13 Inhibitor Poricoic Acid ZI Ameliorates Renal Fibrosis by Mitigating Epithelial‐Mesenchymal Transition

Molecular nutrition & food research, 2019-07, Vol.63 (13), p.e1900132-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism

Journal of proteome research, 2017-04, Vol.16 (4), p.1566-1578

2017

Link zum Volltext

Verfügbarkeit prüfen

Recent advances of gut microbiota in chronic kidney disease patients

Exploration of medicine, 2022-06, Vol.3 (3), p.260-274

Zhao, Ying-Yong

2022

Link zum Volltext

Verfügbarkeit prüfen

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

Frontiers in pharmacology, 2022-03, Vol.13, p.860588-860588

2022

Link zum Volltext

Verfügbarkeit prüfen

An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure

Scientific reports, 2016-02, Vol.6 (1), p.22151-22151, Article 22151

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(351)

Publikationsform

Sprache

Englisch
(366)
Japanisch
(36)
Chinesisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment

Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: A review

Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation

Architectures and accuracy of artificial neural network for disease classification from omics data

Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis

Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease

Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine

Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease

Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation

Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway

Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites

Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy

Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans

Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism

Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy

Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma

Ultra-performance liquid chromatography–mass spectrometry as a sensitive and powerful technology in lipidomic applications

The Matrix Metalloproteinase‐13 Inhibitor Poricoic Acid ZI Ameliorates Renal Fibrosis by Mitigating Epithelial‐Mesenchymal Transition

Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism

Recent advances of gut microbiota in chronic kidney disease patients

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure

Suchergebnisse filtern